生物種
|
リソース名
|
RRC ID
|
タイトル
|
ジャーナル
|
公開日
|
外部リンク
|
ヒト・動物細胞
|
B16 melanoma 4A5(RCB0557)
,
HL60(RCB0041)
|
77409
|
Melanogenesis-inhibitory and cytotoxic activities of diarylheptanoids from Acer nikoense bark and their derivatives.
|
Chem Biodivers |
2012-8-1 |
Pubmed
Full text
|
ヒト・動物細胞
|
MMAc·SF(RCB1200)
|
76385
|
Phenotype-based probabilistic analysis of heterogeneous responses to cancer drugs and their combination efficacy.
|
PLoS Comput Biol |
2020-2-1 |
Pubmed
Full text
|
ヒト・動物細胞
|
Lu-165(RCB1184)
|
72489
|
SMARCA4 deficient tumours are vulnerable to KDM6A/UTX and KDM6B/JMJD3 blockade.
|
Nat Commun |
2021-7-14 |
Pubmed
Full text
|
ヒト・動物細胞
|
HeLa S3
,
A549
,
PC-3
|
71944
|
Synthetic prodrug design enables biocatalytic activation in mice to elicit tumor growth suppression.
|
Nat Commun |
2022-1-10 |
Pubmed
Full text
|
ヒト・動物細胞
|
HEp-2(RCB1889)
|
71643
|
CCL299, a Benzimidazole Derivative Induces G1 Phase Arrest and Apoptosis in Cancer Cells.
|
Anticancer Res |
2021-2-1 |
Pubmed
Full text
|
ヒト・動物細胞
|
HeLa
,
A549
,
MCF7(RCB1904)
,
MKN74(RCB1002)
,
A431
,
PANC-1(RCB2095)
,
MIA Paca2(RCB2094)
,
1B2C6(RCB0795)
,
1C3D3(RCB0796)
|
71639
|
Identification of a Small-Molecule Glucose Transporter Inhibitor, Glutipyran, That Inhibits Cancer Cell Growth.
|
ACS Chem Biol |
2021-8-20 |
Pubmed
Full text
|
ヒト・動物細胞
|
EBC-1(RCB1965)
|
69767
|
PARP7 negatively regulates the type I interferon response in cancer cells and its inhibition triggers antitumor immunity.
|
Cancer Cell |
2021-9-13 |
Pubmed
Full text
|
ヒト・動物細胞
|
Lu99(RCB1900)
|
69197
|
Fragment-Based Discovery of MRTX1719, a Synthetic Lethal Inhibitor of the PRMT5•MTA Complex for the Treatment of MTAP-Deleted Cancers.
|
J Med Chem |
2022-2-10 |
Pubmed
Full text
|
ヒト・動物細胞
|
OV2944-HM-1(RCB1483)
|
69035
|
Anti‑VEGF antibody triggers the effect of anti‑PD‑L1 antibody in PD‑L1low and immune desert‑like mouse tumors.
|
Oncol Rep |
2022-2-1 |
Pubmed
Full text
|
ヒト・動物細胞
|
MKN45(RCB1001)
|
68713
|
Anti-angiogenic and anti-tumor effects of TAK-593, a potent and selective inhibitor of vascular endothelial growth factor and platelet-derived growth factor receptor tyrosine kinase.
|
Cancer Sci |
2013-4-1 |
Pubmed
Full text
|
ヒト・動物細胞
|
HGC-27(RCB0500)
|
67497
|
Discovery of novel ceramide analogs with favorable pharmacokinetic properties and combination with AKT inhibitor against colon cancer.
|
Eur J Med Chem |
2021-4-5 |
Pubmed
Full text
|
ヒト・動物細胞
|
B16F10(RCB2630)
|
66998
|
Sorafenib fails to trigger ferroptosis across a wide range of cancer cell lines.
|
Cell Death Dis |
2021-7-13 |
Pubmed
Full text
|
ヒト・動物細胞
|
LLC(RCB0558)
,
Colon-26(RCB2657)
,
B16/BL6(RCB2638)
,
OP9(RCB1124)
|
66085
|
Lysophosphatidic Acid Receptor 4 Activation Augments Drug Delivery in Tumors by Tightening Endothelial Cell-Cell Contact.
|
Cell Rep |
2017-8-29 |
Pubmed
Full text
|
ヒト・動物細胞
|
Ba/F3
|
66042
|
Mechanisms of Resistance to NTRK Inhibitors and Therapeutic Strategies in NTRK1-Rearranged Cancers.
|
Mol Cancer Ther |
2017-10-1 |
Pubmed
Full text
|
ヒト・動物細胞
|
WERI-Rb-1(RCB2146)
|
65863
|
Neocarzinostatin, Aptamer Conjugates for Targeting EpCAM-positive Tumor Cells.
|
Anticancer Res |
2017-7-1 |
Pubmed
Full text
|
ヒト・動物細胞
|
KP4(RCB1005)
|
65715
|
Mannose impairs tumour growth and enhances chemotherapy.
|
Nature |
2018-11-1 |
Pubmed
Full text
|
ヒト・動物細胞
|
Colon-26(RCB2657)
,
B16/BL6(RCB2638)
|
65456
|
Increasing Tumor Extracellular pH by an Oral Alkalinizing Agent Improves Antitumor Responses of Anti-PD-1 Antibody: Implication of Relationships between Serum Bicarbonate Concentrations, Urinary pH, and Therapeutic Outcomes.
|
Biol Pharm Bull |
2021-1-1 |
Pubmed
Full text
|
ヒト・動物細胞
|
KP4(RCB1005)
|
65155
|
First-in-Man Phase I Trial of the Selective MET Inhibitor Tepotinib in Patients with Advanced Solid Tumors.
|
Clin Cancer Res |
2020-3-15 |
Pubmed
Full text
|
ヒト・動物細胞
|
KP4(RCB1005)
|
65104
|
ABBV-399, a c-Met Antibody-Drug Conjugate that Targets Both MET-Amplified and c-Met-Overexpressing Tumors, Irrespective of MET Pathway Dependence.
|
Clin Cancer Res |
2017-2-15 |
Pubmed
Full text
|
ヒト・動物細胞
|
Sa3(RCB0980)
|
65070
|
Mefenamic acid enhances anticancer drug sensitivity via inhibition of aldo-keto reductase 1C enzyme activity.
|
Oncol Rep |
2017-4-1 |
Pubmed
Full text
|